Table 2 Comparison of visual acuity and optical coherence tomography parameters between the HBOT group and the control group.

From: A comprehensive evaluation of efficacy of hyperbaric oxygen therapy in non-arteritic central retinal artery occlusion using enhanced depth imaging optical coherence tomography

Ā 

Post treatment 1Ā month

Post treatment 3Ā month

Post treatment 6Ā month

HBOT group (n = 29)

Control group (n = 21)

P value*

HBOT group (n = 29)

Control group (n = 21)

P value*

HBOT group (n = 29)

Control group (n = 21)

P value*

VA (logMAR)

1.61 ± 0.93

2.1 ± 0.62

0.049

1.56 ± 0.96

2.1 ± 0.73

0.031

1.55 ± 0.97

2.11 ± 0.78

0.024

CFT (μm)

283.45 ± 45.89

269.91 ± 59.34

0.126

255.85 ± 38.65

235.5 ± 51.92

0.105

245.61 ± 35.43

209.0 ± 48.9

0.004

CCT (μm)

238.32 ± 49.71

227.95 ± 42.69

0.476

245.46 ± 53.46

230.27 ± 41.13

0.233

244.46 ± 51.44

223.5 ± 41.9

0.113

ORLT (μm)

168.93 ± 24.76

170.36 ± 39.11

0.725

161.75 ± 31.13

141.05 ± 35.61

0.059

154.21 ± 27.44

131.77 ± 38.57

0.033

IRLT (μm)

133.71 ± 30.71

144.41 ± 55.03

0.938

107.36 ± 23.83

99.32 ± 20.77

0.077

97.54 ± 23.18

94.95 ± 24.82

0.344

  1. HBOT hyperbaric oxygen therapy, VA visual acuity, CFT central foveal thickness, CCT central choroid thickness, ORLT outer retinal thickness, IRLT inner retinal layer thickness.
  2. *Mann–Whitney U test.